TH cell diversity and response to dupilumab in patients with atopic dermatitis-Reference-Cited by-同舟云学术

TH cell diversity and response to dupilumab in patients with atopic dermatitis

Published:2021-02 Issue:2 Volume:147 Page:756-759
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Trichot Coline,Faucheux Lilith,Karpf Léa,Grandclaudon Maximilien,Pattarini Lucia,Bagot Martine,Mahévas Thibault,Jachiet Marie,Saussine Anne,Bouaziz Jean-David,Soumelis Vassili

Funder

Ligue Contre le Cancer

Agence Nationale de la Recherche

Institut National de la Santé et de la Recherche Médicale

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference9 articles.

1. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion;Morita;Immunity,2011

2. Accelerated T-cell activation and differentiation of polar subsets characterizes early atopic dermatitis development;Esaki;J Allergy Clin Immunol,2016

3. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen T cells from patients with acute or chronic atopic dermatitis;Antunez;Clin Exper Allergy,2004

4. IL-13/IL-22-coproducing T cells, a novel subset, are increased in atopic dermatitis;Teraki;J Allergy Clin Immunol,2013

5. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets;Czarnowicki;J Allergy Clin Immunol,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dupilumab‐induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis;Allergy;2023-08-07

2. Novel insights into atopic dermatitis;Journal of Allergy and Clinical Immunology;2023-05

3. Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate‐to‐severe atopic dermatitis;Allergy;2023-04-18

4. Dupilumab for Atopic Dermatitis—From Clinical Trials to Molecular and Cellular Mechanisms;Dermatitis®;2023-02-01

5. Immunotherapy: State-of-the-art review of therapies and theratypes;Journal of Allergy and Clinical Immunology;2022-12